JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2016, Vol. 54 ›› Issue (8): 22-27.doi: 10.6040/j.issn.1671-7554.0.2016.211

Previous Articles     Next Articles

Effect of liraglutide on leptin and fat content in high fat diet induced obese mice

SHA Sha, Chowdhury Sumon Rahman, CHEN Li, HE Qin, ZHANG Jing, FAN Shanshan, SUN Lei   

  1. Department of Endocrinology, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China
  • Received:2016-03-03 Online:2016-08-10 Published:2016-08-10

Abstract: Objective To observe the effect of liraglutide on the distribution of leptin and fat in high-fat diet induced C57BL/6 obese mice model. Methods A total of 60 C57BL/6 mice aged 4 weeks, body weight(14.03+0.92)g were randomly divided into 2 groups: high-fat diet(40% fat)group(n=45)and normal chow diet(4% fat)group(n=15). The body weight was recorded once a week until the obese mice models were built. Then the 45 obese mice in the high-fat diet group models were randomly divided into 3 groups: liraglutide group[intraperitoneal injection of 100 μg/(kg·d), n=15 ], transferred normal diet group[intraperitoneal injection of 0.017 mL/(kg·d), n=15)] and high fat diet group(n=15). During the 12-week intervention, the body weight of all animals was recorded. The fat content and leptin were monitored by magnetic resonance imaging and enzyme-linked immunosorbent assay. Results The liraglutide group had the lowest body weight than the other 3 groups(P<0.05). The liraglutide group had reduced degree of leptin compared with transferred normal diet group and high fat diet group(P<0.05). The liraglutide group 山 东 大 学 学 报 (医 学 版)54卷8期 -沙莎,等.利拉鲁肽对高脂诱导肥胖小鼠瘦素、脂肪分布及含量的影响 \=-had lower serum lipid level; the triglycerides level was significantly lower than that in the normal chow diet group and high fat diet group(P<0.05); and the total cholesterol level was significantly lower than that in high fat diet group(P<0.05). The liraglutide group was different from the other groups in the mesenteric, epididymal, perirenal, subscapular and subcutaneous fat(P<0.05). Conclusion Liraglutide can significantly reduce the body weight and leptin degree in obese mice and has an effect on regulating lipid and fat distribution.

Key words: Magnetic resonance imaging, Obesity, High fat diet, Liraglutide, Fat content, Leptin

CLC Number: 

  • R589.2
[1] Straub RH. Insulin resistance, selfish brain, and selfish immune system: an evolutionarily positively selected program used in chronic inflammatory diseases[J]. Arthritis Res Ther, 2014, 16(2): 4.
[2] Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance[J]. J Clin Invest, 2003, 112(12):1821-1830.
[3] Stabroth-Akil D, Leifeld L, Pfutzer R, et al. The effect of body weight on the severity and clinical course of ulcerative colitis[J]. Int J Colorectal Dis, 2014, 30(2): 237-242.
[4] Jiang G, Zhang BB. Glucagon and regulation of glucose metabolism[J]. Am J Physiol Endocrinol Metab, 2003, 284(4): 671-678.
[5] Ashcroft FM, Rorsman P. Diabetes mellitus and the beta cell: the last ten years[J]. Cell, 2012, 148(6): 1160-1171.
[6] Inagaki-Ohara K, Okamoto S, Takagi K, et al. Leptin receptor signaling is required for high-fat diet-induced atrophic gastritis in mice[J]. Nutr Metab(Lond), 2016, 13: 7. doi: 10.1186/s12986-016-0066-1.
[7] Iepsen EW, Torekov SS, Holst JJ. Liraglutide for type 2 diabetes and obesity: a 2015 update[J]. Expert Rev Cardiovasc Ther, 2015, 13(7): 753-767.
[8] 申瑞玲, 马婧. 四种肥胖动物造模方法的比较[J]. 动物医学进展, 2007, 28(3): 105-108.
[9] Bi Y, Zhang B, Xu W, et al. Effects of exenatide, insulin, and pioglitazone on liver fat content and body fat distributionsin drug-naive subjects with type 2 diabetes[J]. Acta Diabetol, 2014, 51(5): 865-873.
[10] de Git KC, Adan RA. Leptin resistance in diet-induced obesity: the role of hypothalamic inflammation[J]. Obes Rev, 2015, 16(3): 207-224.
[11] Tian YF, Chang WC, Loh CH, et al. Leptin-mediated inflammatory signaling crucially links visceral fat inflammation to obesity-associated β-cell dysfunction[J]. Life Sci, 2014, 116(1): 51-58.
[12] Noyan-Ashraf MH, Shikatani EA, Schuiki I, et al. A glucagon-like peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesity[J]. Circulation, 2013, 127(1): 74-85.
[13] 李龙辉, 李伶, 杨刚毅, 等. 利拉鲁肽对低脂联素血症小鼠胆固醇代谢相关基因的影响[J]. 中华内分泌代谢杂志, 2011, 27(7): 599-603. LI Longhui, LI Ling, YANG Gangyi, et al. Effect of liraglutide on the expression of genesrelated to cholesterol metabolism in ApoE mice with hypoadiponectinemia[J]. Chin J Endocrinol Metab, 2011, 27(7): 599-603.
[14] Linnemann AK, Neuman JC, Battiola TJ, et al. Glucagon-like peptide-1 regulates cholecystokinin production in β-Cells to protect from apoptosis[J]. Mol Endocrinol, 2015, 29(7): 978-987.
[15] Barreto-Vianna AR, Aguila MB, Mandarim-de-Lacerda CA. Effects of liraglutide in hypothalamic arcuate nucleus of obese mice[J]. Obesity(Silver Spring), 2016, 24(3): 626-633.
[16] Kanoski SE, Ong ZY, Fortin SM, et al. Liraglutide, leptin and their combined effects on feeding: additive intake reduction through common intracellular signalling mechanisms[J]. Diabetes Obes Metab, 2015, 17(3): 285-293.
[17] Scotece M, Abella V, López V, et al. An update on leptin as immunomodulator[J]. Expert Rev Clin Immunol, 2014, 10(9): 1165-1170.
[18] Clemmensen C, Chabenne J, Finan B, et al. GLP-1/glucagon coagonism restores leptin responsiveness in obese mice chronically maintained on an obesogenic diet[J]. Diabetes, 2014, 63(4): 1422-1427.
[19] Mostafa AM, Hamdy NM, El-Mesallamy HO, et al. Glucagon-like peptide 1(GLP-1)-based therapy upregulates LXR-ABCA1/ABCG1 cascade in adipocytes[J]. Biochem Biophys Res Commun, 2015, 468(4): 900-905.
[20] Iepsen EW, Lundgren J, Dirksen C, et al. Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss[J]. Int J Obes(Lond), 2015, 39(5): 834-841.
[21] Kooijman S, Wang Y, Parlevliet ET, et al. Central GLP-1 receptor signalling accelerates plasma clearance of triacylglycerol and glucose by activating brown adipose tissue in mice[J]. Diabetologia, 2015, 58(11): 2637-2646.
[22] Armstrong MJ, Hull D, Guo K, et al. Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis[J]. J Hepatol, 2016, 64(2): 399-408.
[23] López M, Diéguez C, Nogueiras R. Hypothalamic GLP-1: the control of BAT thermogenesis and browning of white fat[J]. Adipocyte, 2015, 4(2): 141-145.
[24] Wei Q, Li L, Chen JA, et al. Exendin-4 improves thermogenic capacity by regulating fat metabolism on brown adipose tissue in mice with diet-induced obesity[J]. Ann Clin Lab Sci, 2015, 45(2): 158-165.
[25] Chae YN, Kim TH, Kim MK, et al. Beneficial effects of evogliptin, a novel dipeptidyl peptidase 4 inhibitor, on adiposity with increased ppargc1a in white adipose tissue in obese mice[J]. PLoS One, 2015, 10(12): e0144064. doi: 10.1371/journal.pone.0144064.
[1] ZHANG Yuan, LI Yang-Min, FENG Rue-Qiu, CHANG Cai-Yun, PAN Hua-Wei, WANG Shu-Mei. Relationship among serum adiponectin level, obesity and insulin resistance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 124-.
[2] ZHAO Wanxia, ZHAN Qunzhang, JIN Ting, LIU Yuxin, QU Chongzheng, WU Jianchun. Mendelian randomization analysis of the causal relationships between gut microbiota, blood metabolites, and obesity [J]. Journal of Shandong University (Health Sciences), 2026, 64(4): 72-82.
[3] JIN Chenxi, SHEN Wei, LI Na, SUN Jianfeng, YANG Chi, GUO Jing. Quantitative analysis of disc-condyle movement following arthroscopic disc repositioning operation for ADDWoR [J]. Journal of Shandong University (Health Sciences), 2025, 63(7): 54-61.
[4] LIU Jingjing, PANG Jing, ZHAO Xiaodan, LIN Xin, FU Min, CHEN Jingjing. Machine learning model based on mammography and DCE-MRI to predict pathological complete response after neoadjuvant therapy in breast cancer: a dual center research [J]. Journal of Shandong University (Health Sciences), 2025, 63(1): 60-72.
[5] FENG Yue, YU Yifan, WU Sijia, LI Hongkai, XUE Fuzhong. Mendelian randomization study of visceral adipose tissue and lung diseases [J]. Journal of Shandong University (Health Sciences), 2024, 62(7): 48-55.
[6] LIU Xiaowen, CAO Yongquan, HOU Mingyuan, YU Dexin. Value of multiple quantitative parameters of EOB-MRI in the risk assessment of progression of HHN in hepatobiliary phase [J]. Journal of Shandong University (Health Sciences), 2024, 62(4): 31-39.
[7] LIU Wen, FENG Wenjuan, YANG Yang, JI Changli, CHAO Lan. Impact of BMI on cumulative birth rate in patients with normal ovarian response [J]. Journal of Shandong University (Health Sciences), 2024, 62(3): 54-60.
[8] LIANG Zhonghao, ZHUANG Xianghua, HUANG Shan, HAN Xiaolin, HUA Mengyu, JU Liping, CHEN Shihong. Proteomic analysis of brown adipose tissue in diet-induced obese female mice [J]. Journal of Shandong University (Health Sciences), 2024, 62(2): 10-19.
[9] WU Siyu, SHEN Yelong, WANG Ximing. Radiomics predicts Ki-67 labeling index in primary central nervous system lymphomas [J]. Journal of Shandong University (Health Sciences), 2024, 62(11): 67-72.
[10] FAN Jiaxu, CHENG Fang, QIAO Junpeng, FEI Haicheng, CHEN Xueyu, ZHAO Yun, JIA Hongying. Mediators or confounders: should obesity be adjusted to estimate the effects of trihalomethanes on thyroid function [J]. Journal of Shandong University (Health Sciences), 2024, 62(1): 102-110.
[11] JIN Xinjuan, ZUO Liping, DENG Zhanhao, LI Anning, YU Dexin. Value of enhanced MRI radiomics in predicting the drug-resistant protein PFKFB3 in 135 cases of hepatocellular carcinoma [J]. Journal of Shandong University (Health Sciences), 2023, 61(6): 79-86.
[12] LI Qing, ZHANG Anna, DU Yansheng, DIAO Jiuzhou, CUI Ruojin, FU Pengrui, YUE Xinyi, ZHOU Qingbo. Influencing factors of the transformation of single demyelinating lesion of spinal cord in 47 cases [J]. Journal of Shandong University (Health Sciences), 2023, 61(5): 37-43.
[13] WANG Lei, ZHANG Shuai, LIU Gang, YOU Shengnan, WANG Zhi, ZHU Shan, CHEN Chao, MA Xinlong, YANG Qiang. Comparison of MRI diagnosis of 140 cases of MCs using intelligent network automatic detection and classification methods [J]. Journal of Shandong University (Health Sciences), 2023, 61(3): 71-79.
[14] YANG Yongqing, ZHAO Peng, WANG Yu, MA Wenjing, TIAN Mimi, CHENG Yani, ZU Lu, LIN Xiangtao. Diagnostic value of extracellular volume fraction in 62 cases of different pathological types of lung cancer [J]. Journal of Shandong University (Health Sciences), 2023, 61(2): 88-94.
[15] JIN Xinjuan, CAI Daxing, FAN Jinlei, DENG Zhanhao, LI Nan, YU Dexin, LI Anning. Differentiation of benign and malignant skin focal protuberant nodules using microscope high-resolution MRI [J]. Journal of Shandong University (Health Sciences), 2023, 61(12): 51-61.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!